Background
 Healthy cells are transformed into tumour cells during the course of a complex, multi-step process called cervical cancer. Several internal and external cues regulate this transition. These triggers include reactive oxygen species (ROS), which are important in the development of tumours. Cervical cancer is the second most common cancer in women worldwide. Cervical cancer is more prevalent in rural areas than in urban areas. Malondialdehyde and glutathione were measured as indicators of lipid peroxidation and endogenous antioxidant, respectively
 Aim and Objectives
 
 To measure serum glutathione and malondialdehyde levels in cervical cancer patients and healthy controls.
 To compare the serum levels of glutathione and malondialdehyde in cervical cancer patients and healthy controls.
 
 Materials and Methods
 This hospital-based cross-sectional study was carried out in departments of biochemistry, pathology, and gynaecology at SGT Hospital in Budhera, Gurugram's Faculty of Medicine and Health Sciences. As the control group, we used 50 age-matched, healthy volunteers from the general community. Each participant in both groups were fully informed of the study's aims before providing a signed and informed consent. The clearance of the institutional ethics committee was taken before starting the sample collection. The serum is seperated from the clot in the plain tube by centrifuging the sample at 3000 rpm for 10 minutes. After the blood has been centrifuged at 3000 rpm in the lithium heparin tube, the plasma is decanted. A commercially available ELISA kit (MyBioSource) is used to quantify malondialdehyde and glutathione levels
 Results
 Patients with cervical cancer had a significantly higher level of serum MDA and lower value of serum Glutathine when compare with controls having mean and standard deviation for MDA (5.5 ±1.48 nmol/ml and 3.4 ±0.87 nmol/ml) and Glutathione (4.5±1.5 Mm and11.9±2.7 Mm) .
 Conclusion
 In conclusion, decreased antioxidative enzyme activity and enhanced lipid peroxidation are signs of oxidative stress in cervical cancer, which is more obvious in advanced stages because of the increased tumour burden. Antioxidant supplements may slow the disease's progression in cervical cancer sufferers.